Nanobiotix (NBTX) Non-Current Assets (2018 - 2025)
Nanobiotix (NBTX) recorded quarterly Non-Current Assets of $5.8 million in Q4 2025, down 2.5% quarter-over-quarter from $6.0 million in Q2 2025, and down 8.29% on a YoY basis from $6.4 million in Q4 2024.
Nanobiotix (NBTX) Non-Current Assets (2018 - 2025) Analysis & Trends
Nanobiotix's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.8 million for Q4 2025.
- In Q4 2025, Non-Current Assets fell 8.29% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (down 8.29% YoY), while the FY2025 annual figure was $5.7 million, down 10.99% from the prior year.
- Non-Current Assets was $5.8 million for Q4 2025 at Nanobiotix, down from $6.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $10.0 million in Q4 2021 to a low of $5.8 million in Q4 2025.
- Historically, Non-Current Assets has averaged $7.5 million across 5 years, with a median of $7.2 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Non-Current Assets dropped 4.85% in 2021, then declined 24.1% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $10.0 million in 2021, then slipped by 24.1% to $7.6 million in 2022, then decreased by 6.69% to $7.1 million in 2023, then fell by 9.88% to $6.4 million in 2024, then decreased by 8.29% to $5.8 million in 2025.
- The last three Non-Current Assets figures came in at $5.8 million (Q4 2025), $6.0 million (Q2 2025), and $6.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 39.71 Mn |
| 10 | Nanobiotix | 59.17 Mn | -2.23 Mn | - | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.83 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Jun 30, 2024 | 6.70 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Dec 31, 2022 | 7.56 Mn |
| Jun 30, 2022 | 8.29 Mn |
| Dec 31, 2021 | 9.96 Mn |
| Jun 30, 2021 | 9.69 Mn |
| Dec 31, 2020 | 10.47 Mn |
| Dec 31, 2019 | 11.16 Mn |
| Dec 31, 2018 | 4.05 Mn |